The DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.
Disruption of the A3 Adenosine Receptor Gene in Mice and Its Effect on Stimulated Inflammatory Cells
Open accessAbstract
The A(3) adenosine receptor (A3AR) is one of four receptor subtypes for adenosine and is expressed in a broad spectrum of tissues. In order to study the function of A3AR, a mouse line carrying a mutant A(3) allele was generated. Mice homozygous for targeted disruption of the A3AR gene, A3AR(-/-), are fertile and visually and histologically indistinguishable from wild type mice. The lack of a functional receptor in the A3AR(-/-) mice was confirmed by molecular and pharmacological analyses. The absence of A3AR protein expression in the A3AR(-/-) mice was demonstrated by lack of N(6)-(4-amino-3-[(125)I]iodobenzyl)adenosine binding to bone marrow-derived mast cell membranes that were found to express high levels of A3AR in wild type mice. In A3AR(-/-) mice, the density of A(1) and A(2A) adenosine receptor subtypes was the same as in A3AR(+/+) mice as determined by radioligand binding to brain membranes. Additionally, A(2B) receptor transcript expression was not affected by ablation of the A3AR gene. A3AR(-/-) mice have basal heart rates and arterial blood pressures indistinguishable from A3AR(+/+) mice. Functionally, in contrast to wild type mice, adenosine and the A3AR-specific agonist, 2-chloro-N(6)-(3-iodobenzyl)-adenosine-5'-N-methyl-carboxamide (2-Cl-IB-MECA), elicit no potentiation of antigen-dependent degranulation of bone marrow-derived mast cells from A3AR(-/-) mice as measured by hexosaminidase release. Also, the ability of 2Cl-IB-MECA to inhibit lipopolysaccharide-induced tumor necrosis factor-alpha production in vivo was decreased in A3AR(-/-) mice in comparison to A3AR(+/+) mice. The A(2A) adenosine receptor agonist, 2-p-(2-carboxyethyl)phenylamino)-5'-N-ethylcarboxamidoadenosine, produced inhibition of lipopolysaccharide-stimulated tumor necrosis factor-alpha production in both A3AR(-/-) and A3AR(+/+) mice. These results show that the inhibition in vivo can be mediated by multiple subtypes, specifically the A(3) and A(2A) adenosine receptors, and A3AR activation plays an important role in both pro- and anti-inflammatory responses.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Molecular cloning: A laboratory manual
Deininger, P. (1990) · Analytical Biochemistry · doi:10.1016/0003-2697(90)90595-z · Cited by 84,682
A simple salting out procedure for extracting DNA from human nucleated cells
Miller, S. A., Dykes, D. D., & Polesky, H. F. (1988) · Nucleic Acids Research · doi:10.1093/nar/16.3.1215 · Cited by 20,330
HPRT-deficient (Lesch–Nyhan) mouse embryos derived from germline colonization by cultured cells
Hooper, M., Hardy, K., Handyside, A., Hunter, S., & Monk, M. (1987) · Nature · doi:10.1038/326292a0 · Cited by 1,217
Characterization of the A2 adenosine receptor labeled by [3H]NECA in rat striatal membranes.
Bruns, R. F., Lu, G. H., & Pugsley, T. A. (1986) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)10259-9 · Cited by 830
The cardiac effects of adenosine
Belardinelli, L., Linden, J., & Berne, R. M. (1989) · Progress in Cardiovascular Diseases · doi:10.1016/0033-0620(89)90015-7 · Cited by 762
Molecular cloning and characterization of an adenosine receptor: the A3 adenosine receptor.
Zhou, Q. Y., Li, C., Olah, M. E., Johnson, R. A., Stiles, G. L., & Civelli, O. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.16.7432 · Cited by 658
Haskó, G., Szabó, C., Németh, Z. H., Kvetan, V, Pastores, S. M., & Vizi, E. S. (1996) · The Journal of Immunology · doi:10.4049/jimmunol.157.10.4634 · Cited by 536
Adenosine receptors: pharmacology, structure-activity relationships, and therapeutic potential
Jacobson, K. A., Van Galen, P. J. M., & Williams, M. (1992) · Journal of Medicinal Chemistry · doi:10.1021/jm00081a001 · Cited by 456
Ramkumar, V., Stiles, G. L., Beaven, M. A., & Ali, H. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)85277-8 · Cited by 448
Molecular cloning and characterization of the human A3 adenosine receptor.
Salvatore, C. A., Jacobson, M. A., Taylor, H. E., Linden, J., & Johnson, R. G. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.21.10365 · Cited by 424
Self-citationDombrowicz, D., Flamand, V., Brigman, K. K., Koller, B. H., & Kinet, J.-P. (1993) · Cell · doi:10.1016/0092-8674(93)90540-7 · Cited by 399
Self-citationLinden, J. (1994) · Trends in Pharmacological Sciences · doi:10.1016/0165-6147(94)90011-6 · Cited by 389
Feoktistov, I., & Biaggioni, I. (1995) · Journal of Clinical Investigation · doi:10.1172/jci118245 · Cited by 363
Inhibition of TNF-α expression by adenosine: role of A3 adenosine receptors
Sajjadi, F. G., Takabayashi, K., Foster, A. C., Domingo, R. C., & Firestein, G. S. (1996) · The Journal of Immunology · doi:10.4049/jimmunol.156.9.3435 · Cited by 352
Adenosine A3 receptor stimulation and cerebral ischemia
Von Lubitz, D. K. J. E., Lin, R. C.-S., Popik, P., Carter, M. F., & Jacobson, K. A. (1994) · European Journal of Pharmacology · doi:10.1016/0014-2999(94)90523-1 · Cited by 276
Potentiation of Mast Cell Mediator Release by Adenosine
Marquardt, D. L., Parker, C. W., & Sullivan, T. J. (1978) · The Journal of Immunology · doi:10.4049/jimmunol.120.3.871 · Cited by 267
Schwartz, L. B., Austen, K. F., & Wasserman, S. I. (1979) · PubMed · Cited by 259
BindingDB (2012) · PubMed · doi:10.7270/q2m9077b · Cited by 216
Immunologic Release of β-Hexosaminidase and β-Glucuronidase from Purified Rat Serosal Mast Cells
Schwartz, L. B., Austen, K. F., & Wasserman, S. I. (1979) · The Journal of Immunology · doi:10.4049/jimmunol.123.4.1445 · Cited by 206
Linden, J., Taylor, H. E., Robeva, A. S., Tucker, A. L., Stehle, J. H., Rivkees, S. A., Fink, J. S., & Reppert, S. M. (1993) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)13220-3 · Cited by 204
A physiological role of the adenosine A 3 receptor: Sustained cardioprotection
Liang, B. T., & Jacobson, K. A. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.12.6995 · Cited by 201
Auchampach, J. A., Jin, X., Wan, T. C., Caughey, G. H., & Linden, J. (1997) · Molecular Pharmacology · doi:10.1124/mol.52.5.846 · Cited by 201
Molecular cloning of a novel putative G‐protein coupled receptor expressed during rat spermiogenesis
Meyerhof, W., Müller-Brechlin, R., & Richter, D. (1991) · FEBS Letters · doi:10.1016/0014-5793(91)80674-r · Cited by 189
Rafferty, P., Beasley, R. W., & Holgate, S. T. (1987) · American Review of Respiratory Disease · doi:10.1164/ajrccm/136.2.369 · Cited by 184
Adenosine A3 Receptor Expression and Function in Eosinophils
WALKER, B. A. M., Jacobson, M. A., Knight, D. A., Salvatore, C., Weir, T., Zhou, D., & Bai, T. R. (1997) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/ajrcmb.16.5.9160835 · Cited by 164
Self-citationA role for central A3‐adenosine receptors
Jacobson, K. A., Nikodijević, O., Shi, D., Gallo‐Rodriguez, C., Olah, M. E., Stiles, G. L., & Daly, J. W. (1993) · FEBS Letters · doi:10.1016/0014-5793(93)81608-3 · Cited by 146
Adenosine Potentiates Mediator Release from Human Lung Mast Cells
Peachell, P. T., Columbo, M., Kagey-Sobotka, A., Lichtenstein, L. M., & Marone, G. (1988) · American Review of Respiratory Disease · doi:10.1164/ajrccm/138.5.1143 · Cited by 144
Fozard, J. R., & Carruthers, A. M. (1993) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1993.tb13522.x · Cited by 118
Inhibition of human monocyte TNF production by adenosine receptor agonists
Vraux, V. L., Chen, Y. L., Masson, I., Sousa, M. D., Giroud, J., Florentin, I., & Chauvelot‐Moachon, L. (1993) · Life Sciences · doi:10.1016/0024-3205(93)90632-d · Cited by 112
cDNA cloning and sequence analysis of the human A3 adenosine receptor
Sajjadi, F. G., & Firestein, G. S. (1993) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/0167-4889(93)90077-3 · Cited by 84
Role of A2A adenosine receptors in inflammation
Sullivan, G. W., & Linden, J. M. (1998) · Drug Development Research · doi:10.1002/(sici)1098-2299(199811/12)45:3/4<103::aid-ddr4>3.0.co;2-w · Cited by 79
van Schaick, E. A., Jacobson, K. A., Kim, H. O., et al. (1996) · European Journal of Pharmacology · doi:10.1016/0014-2999(96)00373-1 · Cited by 67
Molineaux, S. M., Casano, F. J., Rolando, A. M., Peterson, E. P., Limjuco, G. A., Chin, J., Griffin, P. R., Calaycay, J. R., DING, G. J.-F., & Yamin, T.-T. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.5.1809 · Cited by 61
Cloning, Expression and Pharmacological Characterization of Rabbit Adenosine A1 and A3 Receptors
Hill, R. J. W., Oleynek, J. J., Hoth, C. F., Kiron, M. A. R., Weng, W., Wester, R. T., Tracey, W. R., Knight, D. R., Buchholz, R. A., & Kennedy, S. P. (1997) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)36375-x · Cited by 59
Tl, B., Borcherding, D. R., Edwards, C., & McWhinney, C. D. (1997) · PubMed · Cited by 49
Rottem, M., Barbieri, S., Kinet, J.-P., & Metcalfe, D. D. (1992) · Blood · doi:10.1182/blood.v79.4.972.972 · Cited by 45
Cited by
International Union of Pharmacology. XXV. Nomenclature and Classification of Adenosine Receptors
Fredholm, B. B., IJzerman, A. P., Jacobson, K. A., Klotz, K.-N., & Linden, J. (2001) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01511-4 · Cited by 2,585
Adenosine Receptors as Therapeutic Targets
Jacobson, K. A., & Gao, Z.-G. (2006) · Nature Reviews Drug Discovery · doi:10.1038/nrd1983 · Cited by 1,431
Fredholm, B. B., IJzerman, A. P., Jacobson, K. A., Linden, J., & Müller, C. E. (2011) · Pharmacological Reviews · doi:10.1124/pr.110.003285 · Cited by 1,301
Adenosine receptors: therapeutic aspects for inflammatory and immune diseases
Haskó, G., Linden, J., Cronstein, B., & Pacher, P. (2008) · Nature Reviews Drug Discovery · doi:10.1038/nrd2638 · Cited by 1,217
Bours, M. J. L., Swennen, E. L. R., Di Virgilio, F., Cronstein, B. N., & Dagnelie, P. C. (2006) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2005.04.013 · Cited by 1,030
Metadata
- Authors
- Salvatore, C. A., Tilley, S. L., Latour, A. M., Fletcher, D. S., Koller, B. H., & Jacobson, M. A.
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2000-02
- Volume
- 275
- Issue
- 6
- Pages
- 4429-4434
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2077747679
- Cited by
- 303
- References
- 36
- FWCI
- 12.08
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.